@mgregory

Our apologies. The above was posted prematurely.

Please note that as per PAAB code 7.3.1a, "The URL may be supplemented, but not replaced, by an electronic coding system, such as a QR code or a bar code".

For print media, please be reminded that the telephone number must be accompanied with the URL +/- the QR code.

@jennifer-carroll Thank you 🙂 this helps!

Hi @maryssa

Although 'price' generally refers to the monetary amount associated with the patient's acquisition of the sponsor's prescription product, insurance coverage and corporate service programs addressing acquisition costs could also potentially be presented in a manner that complies with the name, price, and quantity restriction. Acceptability of the proposed claim in the above question may be possible depending on the balance of the context. This can be addressed during the review process.

Hi @cchristopoulos

Descriptive statistics alone, may not be used to support promotional claims. Depending on the data, we may consider presentation in an informational, claim neutral context. Applicability of icons, formatting or disclosures would depend on the study design, endpoints, etc. We are unable to provide specifics without seeing the data and proposed APS. We suggest our opinion service if further direction is required.

Hi @dnewman

The “Health Canada Distinction between advertising and other activities” document addresses Canadian conferences and International conferences held in Canada. General corporate APS informing HCPs of upcoming international conferences (print or digital) may be distributed to Canadian HCPs and may be subject to PAAB review per code section 7.4, depending on the content. Use in branded material would require PAAB review and may be limited to avoid linkage issues. Material (including digital), emanating from the international conference outside of Canada or from the global division of the pharmaceutical company, is outside the scope of PAAB.